Aptose Biosciences Inc. - Common Shares

CUSIP: 03835T200

Q4 2016 13F Holders as of 31 Dec 2016

Holder snapshot 6 signals
Share change
-209,312
SEC-reported price per share
$1.40
Indexed holders
11
Value change
-$283,788
Number of buys
5
Number of sells
6
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
2,556,332

Security key

03835T200

Report period

Q4 2016

Indexed institutions

11

Top holders

10

Ownership snapshot

Top reported holders of 03835T200 - Aptose Biosciences Inc. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FRANKLIN TEMPLETON INC
Disclosed value leader
FRANKLIN TEMPLETON INC
Comparable rows
0/10
Latest evidence
30 Sep 2016
13F Highest disclosed value: $3,195,000 10 rows are not safely comparable across share classes. Showing 1-6 of 10 holder rows.

Quick read

FRANKLIN TEMPLETON INC has the largest disclosed position value at $3.2M.

0 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FRANKLIN TEMPLETON INC's linked filing trail.
Disclosed position value Top 5
FRANKLIN TEMPLETON INC $3.2M
Cormorant Asset Management, LP $2.23M
BAKER BROS. ADVISORS LP $909K
BANK OF MONTREAL /CAN/ $112K
ROYAL BANK OF CANADA $46K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 10 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FRANKLIN TEMPLETON INC
13F
Company
13F
—
denominator unverified
$3,195,000
1,416,666 shares
— 30 Sep 2016
Cormorant Asset Management, LP
13F
Company
13F
—
denominator unverified
$2,229,000
990,579 shares
— 30 Sep 2016
BAKER BROS. ADVISORS LP
13F
Company
13F
—
denominator unverified
$909,000
404,211 shares
— 30 Sep 2016
BANK OF MONTREAL /CAN/
13F
Company
13F
—
denominator unverified
$112,000
49,724 shares
— 30 Sep 2016
ROYAL BANK OF CANADA
13F
Company
13F
—
denominator unverified
$46,000
20,706 shares
— 30 Sep 2016
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$20,000
8,932 shares
— 30 Sep 2016
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2016

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
11
Shares
2,688,809
Indexed holders
11
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 indexed holders
10
Q4 2016 indexed holders
11
Indexed holder difference
1
Investor Q3 2016 Shares Q4 2016 Shares Share Diff Share Chg % Q3 2016 value Q4 2016 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .